Evidence map›Paper›PMID 33226027›Full record

ArticleJournal of visualized experiments : JoVE2020

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions.

Benedetta Assetta, Changyong Tang, Jing Bian, Ryan O'Rourke, Kevin Connolly, Thomas Brickler, Sundari Chetty, Yu-Wen Alvin Huang

Erratum issuedOpen access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Benedetta Assetta *Department of Molecular Biology, Cell Biology and Biochemistry, Brown University.
Changyong Tang *Department of Molecular Biology, Cell Biology and Biochemistry, Brown University; Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University.
Jing Bian *Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine.
Ryan O'RourkeDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University.
Kevin ConnollyDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University.
Thomas BricklerDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine.
Sundari ChettyDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine.
Yu-Wen Alvin HuangDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University; Department of Neurology, Warren Alpert Medical School of Brown University; Center for Translational Neuroscience, Robert J. and Nancy D. Carney Institute for Brain Science and Brown Institute for Translational Science, Brown University; alvinhuang@brown.edu.
John Brown University · USStanford University · US

Funding

Predoctoral Training in Molecular, Cellular, and Biochemical SciencesT32GM136566 · NIGMS · BROWN UNIVERSITY · PI Mark Aikens Johnson, Erica Nicole Larschan · 2020 to 2026
$3.1M
A Molecular Signaling Pathway Underlying Differential Predisposition of ApoE4 Genotype to Alzheimer's DiseaseR00AG054616 · NIA · BROWN UNIVERSITY · PI HUANG, YU-WEN ALVIN · 2019 to 2021
$722k
NIA NIH HHS R00 AG054616NIGMS NIH HHS T32 GM136566
6 · The paper itself

Abstract

In Alzheimer's disease (AD) and other neurodegenerative disorders, oligodendroglial failure is a common early pathological feature, but how it contributes to disease development and progression, particularly in the gray matter of the brain, remains largely unknown. The dysfunction of oligodendrocyte lineage cells is hallmarked by deficiencies in myelination and impaired self-renewal of oligodendrocyte precursor cells (OPCs). These two defects are caused at least in part by the disruption of interactions between neuron and oligodendrocytes along the buildup of pathology. OPCs give rise to myelinating oligodendrocytes during CNS development. In the mature brain cortex, OPCs are the major proliferative cells (comprising ~5% of total brain cells) and control new myelin formation in a neural activity-dependent manner. Such neuron-to-oligodendrocyte communications are significantly understudied, especially in the context of neurodegenerative conditions such as AD, due to the lack of appropriate tools. In recent years, our group and others have made significant progress to improve currently available protocols to generate functional neurons and oligodendrocytes individually from human pluripotent stem cells. In this manuscript, we describe our optimized procedures, including the establishment of a co-culture system to model the neuron-oligodendrocyte connections. Our illustrative results suggest an unexpected contribution from OPCs/oligodendrocytes to the brain amyloidosis and synapse integrity and highlight the utility of this methodology for AD research. This reductionist approach is a powerful tool to dissect the specific hetero-cellular interactions out of the inherent complexity inside the brain. The protocols we describe here are expected to facilitate future studies on oligodendroglial defects in the pathogenesis of neurodegeneration.

Indexed as

Cell CommunicationCell Culture TechniquesCell DifferentiationCell LineageCoculture TechniquesDimethyl SulfoxideHEK293 CellsHumansMyelin SheathNeuronsOligodendrogliaPluripotent Stem CellsDimethyl Sulfoxide

Identifiers

PMID33226027
PMCPMC7739515
OpenAlexW3102992749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.